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R72British researchers have been 
denied permission to create 
controversial human–animal-
derived hybrid embryos until 
doubts about the ethics and 
scientifi c value of the research are 
addressed.
The Human Fertilisation and 
Embryology Authority said it was 
deferring a decision on whether 
to grant licences to teams from 
King’s College London and 
Newcastle University until a 
wide- ranging consultation on the 
issue concluded in the autumn.
Scientists claim that stem 
cells from hybrid embryos will be 
vital to unravel the mysteries of 
Alzheimer’s, Parkinson’s and motor 
neurone diseases, and will pave 
the way for techniques capable 
of transforming skin cells from 
an adult into different tissues and 
organs. Opponents protest that the 
creation of embryos that are part 
human, part animal is abhorrent.
Last month, a government white 
paper outlining plans to update 
regulations included proposals to 
ban the creation of hybrid embryos. 
The government is due to produce 
a draft bill on the issue next 
month, which will be scrutinised 
by a parliamentary committee 
before debate. Scientists believe 
it is possible to harvest human 
embryonic stem cells from cloned 
embryos, which are created by 
transplanting the genetic material 
from an adult cell into a hollowed-
out egg. Human eggs are in short 
supply and subject to other ethical 
issues but, with plentiful supplies 
of animal eggs, scientists believe 
they could perfect the technique 
of creating embryos as a source of 
stem cells in this way.
The hybrid embryos would be 
more than 99 per cent human, 
The UK has some of the most 
supportive legislation for research 
on human embryonic stem 
cells but the latest proposal 
for human– animal hybrids has 
prompted wider consultation. 
Nigel Williams reports.
Plans for 
human– animal 
stem cells stalledGrown alone: A micrograph of a purely human-derived embryonic stem cell. (Picture: 
Science Photo Library.)with animal DNA contained in 
mitochondria.
Experts met at the HFEA 
ahead of last month’s decision 
and decided it was premature to 
issue research licences. Angela 
McNab, the chief executive, 
said in a statement: “This has 
proved complex and challenging 
as the law in this area is far 
from explicit and this area of 
research would be a signifi cant 
step change in UK science. 
There is not clear agreement 
within the scientifi c community 
about the need for and benefi ts 
of this science. The authority 
felt that it is important that we 
go through the issues and the 
science thoroughly and test the 
claims about the benefi ts of this 
research.”Stephen Minger, head of the 
King’s College team, said: “We’re 
happy for the consultation to 
happen if it means that the public 
and the HFEA are more informed 
about what we want to do.”
But some commentators were 
less generous about the delay 
over a decision. The Observer 
newspaper commented that, in 
the end, “there can only be two 
outcomes: the government and 
HFEA will either ban hybrids or 
approve them. The fi rst option 
would be calamitous for it 
would end research with a vast 
potential to alleviate suffering. 
The second — to approve — 
will merely mean that life-
saving research will have been 
suspended for almost a year 
thanks to ministerial bungling.”
